References
Bounoua M, Valeyrie-Allanore L, Sekula P, et al. Evaluation prospective des séquelles de syndrome de Stevens-Johnson et de nécrolyse épidermique toxique dans une cohorte européenne de 339 malades. Ann Dermatol Venereol. 2007;134:7S12.
Butt TF, Cox AR, Oyebode JR, et al. Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis. Drug Saf. 2012;35(12):1159–70.
An example to us all. Prescrire Int. 2012;21:200.
Stevens-Johnson Syndrome Foundation [online]. Available from http://sjsupport.org/. Accessed 19 Nov 2012.
Valeyrie-Allanore L, Ingen-Housz-Oro S, Colin A, et al. Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases [in French]. Ann Dermatol Venereol. 2011;138:694–7.
Gaultier F, Rochefort J, Landru MM, et al. Severe and unrecognized dental abnormalities after drug-induced epidermal necrolysis. Arch Dermatol. 2009;145:1332–3.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roujeau, JC. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Drug Saf 36, 145–146 (2013). https://doi.org/10.1007/s40264-012-0008-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40264-012-0008-4